$ICCT
iCoreConnect Inc. Stock $icct

$icct Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000147793224002244 Filed on April 19, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$3.088M		$8.152M
YoY Change	66.36%
Cost Of Revenue	$606.6K		$2.029M
YoY Change	25.33%		-9.54%
Gross Profit	$2.481M		$6.122M
YoY Change	80.84%		6.58%
Gross Profit Margin	80.36%		75.11%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$17.43K
YoY Change			-98.65%
% of Gross Profit			0.28%
Operating Expenses	$9.969M		$16.40M
YoY Change	186.41%		1400.56%
Operating Profit	-$7.488M		-$10.28M
YoY Change	866.78%		840.34%
Interest Expense	$501.6K		$1.109M
YoY Change	-181.86%		-6.15%
% of Operating Profit
Other Income/Expense, Net	$0.00		-$5.275M
YoY Change	-100.0%		-546.26%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	-$10.90M		-$15.92M
YoY Change	-66116.81%		12556.4%
Net Earnings / Revenue	-352.84%		-195.3%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	10.15M shares	8.951M shares	7.350M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$247.2K	$1.219M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$703.8K	$563.9K
Other Receivables
Total Short-Term Assets	$1.443M	$3.508M
YoY Change	978.63%	370.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$183.6K	$202.4K
YoY Change	-82.56%	-80.13%
Goodwill	$1.485M	$1.485M
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$15.99M	$12.18M
YoY Change	-81.35%	-85.45%
TOTAL ASSETS
Total Short-Term Assets	$1.443M	$3.508M
Total Long-Term Assets	$15.99M	$12.18M
Total Assets	$17.43M	$15.69M
YoY Change	-79.7%	-81.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due	$6.544M	$4.720M
YoY Change	-5.29%	10.3%
Total Short-Term Liabilities	$12.94M	$8.876M
YoY Change	474.18%	1195.95%
LONG-TERM LIABILITIES
Long-Term Debt	$2.943M	$1.420M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$4.081M	$2.366M
YoY Change	440.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.94M	$8.876M
Total Long-Term Liabilities	$4.081M	$2.366M
Total Liabilities	$17.02M	$11.24M
YoY Change	655.28%	1541.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$131.6M	-$115.0M
YoY Change	6105.12%	89035.18%
Common Stock	$1.040K	$1.007K
YoY Change	392.89%	377.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$410.6K	$4.444M
YoY Change
Total Liabilities & Shareholders Equity	$17.43M	$15.69M
YoY Change	-79.7%	-81.42%

Cashflow Statement

Concept	2024 Q2	2023
OPERATING ACTIVITIES
Net Income	-$10.90M	-$15.92M
YoY Change	-66116.81%	12556.4%
Depreciation, Depletion And Amortization		$17.43K
YoY Change		-98.65%
Cash From Operating Activities		-$8.825M
YoY Change		-2756.72%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$10.21M
YoY Change		-87.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$2.881M
YoY Change		11424.1%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$20.06M
YoY Change		-76.08%
NET CHANGE
Cash From Operating Activities		-$8.825M
Cash From Investing Activities		-$10.21M
Cash From Financing Activities		$20.06M
Net Change In Cash		$1.023M
YoY Change		96.07%
FREE CASH FLOW
Cash From Operating Activities		-$8.825M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	icct	Customer Relationships Net CustomerRelationshipsNet	2980412	usd
CY2023Q4	icct	Forward Purchase Agreement ForwardPurchaseAgreement	5484556	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001906133
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3755209	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10068477	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6076078	shares
CY2022	icct	Weighted Average Exercise Price Of Warrants Ending WeightedAverageExercisePriceOfWarrantsEnding	2.98
CY2022	icct	Aggregate Intrinsic Value Of Warrants Beginning AggregateIntrinsicValueOfWarrantsBeginning	0	usd
CY2022	icct	Aggregate Intrinsic Value Of Warrants Ending AggregateIntrinsicValueOfWarrantsEnding	0	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	540000	usd
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	1392935	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1484966	usd
CY2023Q3	us-gaap	Goodwill Goodwill	1484966	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41309
CY2023	dei	Entity Registrant Name EntityRegistrantName	iCoreConnect Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2462502
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	529 E Crown Point Road
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 250
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Ocoee
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34761
CY2023	dei	City Area Code CityAreaCode	888
CY2023	dei	Local Phone Number LocalPhoneNumber	810-7706
CY2023	dei	Security12b Title Security12bTitle	Common stock, par value $0.0001 per share
CY2023	dei	Trading Symbol TradingSymbol	ICCT
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	85200000	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10150753	shares
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum LLP
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1219358	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	196153	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	414809	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	480706	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1091668	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	74194	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	944487	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	531061	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	79428	usd
CY2022Q4	icct	Customer Relationships Net CustomerRelationshipsNet	2350380	usd
CY2022Q4	icct	Forward Purchase Agreement ForwardPurchaseAgreement	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1484966	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	12178179	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	5464516	usd
CY2022Q4	us-gaap	Assets Assets	6556184	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2336174	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	169417	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4034865	usd
CY2022Q4	icct	Related Party Notes Payable Current RelatedPartyNotesPayableCurrent	244666	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	119598	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	13847	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6798969	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1449261	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	809458	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2258719	usd
CY2022Q4	us-gaap	Liabilities Liabilities	9057688	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3755209	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	376	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10068477	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6076078	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1007	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	608	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	119481543	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	80359848	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-115038758	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-82861960	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4444168	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2501504	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15686504	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6556184	usd
CY2023	us-gaap	Revenues Revenues	8151587	usd
CY2022	us-gaap	Revenues Revenues	7987902	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2029145	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2243253	usd
CY2023	us-gaap	Gross Profit GrossProfit	6122442	usd
CY2022	us-gaap	Gross Profit GrossProfit	5744649	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15124081	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9254670	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1274963	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1292085	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	16399044	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	10546755	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-10276602	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-4802106	usd
CY2023	us-gaap	Interest Expense InterestExpense	1109388	usd
CY2022	us-gaap	Interest Expense InterestExpense	785406	usd
CY2023	us-gaap	Financing Interest Expense FinancingInterestExpense	1287916	usd
CY2022	us-gaap	Financing Interest Expense FinancingInterestExpense	426419	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	105676	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022	us-gaap	Other Expenses OtherExpenses	65893	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5275061	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1277718	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-15551663	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-6079824	usd
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	1794704	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	368699	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-15920362	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-7874528	usd
CY2023	icct	Net Loss Per Share Basic And Diluted NetLossPerShareBasicAndDiluted	-2.17
CY2022	icct	Net Loss Per Share Basic And Diluted NetLossPerShareBasicAndDiluted	-1.37
CY2023	icct	Weighted Average Number Of Shares Basic And Diluted WeightedAverageNumberOfSharesBasicAndDiluted	7349541	shares
CY2022	icct	Weighted Average Number Of Shares Basic And Diluted WeightedAverageNumberOfSharesBasicAndDiluted	5768249	shares
CY2022	icct	Balances As Previously Reported Amount BalancesAsPreviouslyReportedAmount	1005291	usd
CY2022	icct	Retroactive Application Of Reverse Capitalization Amount RetroactiveApplicationOfReverseCapitalizationAmount	-10243017	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9237726	usd
CY2022	icct	Stock Issued For Cash Amount StockIssuedForCashAmount	450000	usd
CY2022	icct	Origination Fee In Convertible Debt Agreement OriginationFeeInConvertibleDebtAgreement	426419	usd
CY2022	icct	Stock Issued For Conversion Of Debt Amount StockIssuedForConversionOfDebtAmount	22387	usd
CY2022	icct	Stock Repurchased And Cancelled As Part Of Settlement Amount StockRepurchasedAndCancelledAsPartOfSettlementAmount	-100000	usd
CY2022	icct	Exercise Of Common Stock Options Amount ExerciseOfCommonStockOptionsAmount	2100	usd
CY2022	icct	Repurchase Of Common Stock Warrants RepurchaseOfCommonStockWarrants	-45000	usd
CY2022	icct	Stock Compensation Expense Amount StockCompensationExpenseAmount	1817123	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-6079824	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12744521	usd
CY2023	icct	Balances As Previously Reported Amount BalancesAsPreviouslyReportedAmount	-2501504	usd
CY2023	icct	Retroactive Application Of Reverse Capitalization Amount RetroactiveApplicationOfReverseCapitalizationAmount	-10243309	usd
CY2022Q4	icct	Stockholders Equity After Adjustment StockholdersEquityAfterAdjustment	-12744813	usd
CY2023	icct	Stock Issued For Cash Amount StockIssuedForCashAmount	2880985	usd
CY2023	icct	Origination Fee In Convertible Debt Agreement Amount OriginationFeeInConvertibleDebtAgreementAmount	1040165	usd
CY2023	icct	Stock Issued For Conversion Of Debt Amount StockIssuedForConversionOfDebtAmount	5747497	usd
CY2023	icct	Stock Compensation Expense Amount StockCompensationExpenseAmount	1942036	usd
CY2023	icct	Issuance Of Series A Preferred Stock On Merger Amount IssuanceOfSeriesAPreferredStockOnMergerAmount	-17847298	usd
CY2023	icct	Common Stock Issued On Exercise Of Options Amount CommonStockIssuedOnExerciseOfOptionsAmount	-5920	usd
CY2023	icct	Conversion Of Series A Preferred Stock To Common Stock Amount ConversionOfSeriesAPreferredStockToCommonStockAmount	0	usd
CY2023	icct	Series A Preferred Stock Issued For Cash Amount SeriesAPreferredStockIssuedForCashAmount	465000	usd
CY2023	icct	Stock Issued For Purchase Of Assets Of Preferred Dental Amount StockIssuedForPurchaseOfAssetsOfPreferredDentalAmount	400000	usd
CY2023	icct	Warrant Agreement Amount WarrantAgreementAmount	1987460	usd
CY2023	icct	Origination Fee On Equity Line Of Credit Amount OriginationFeeOnEquityLineOfCreditAmount	600000	usd
CY2023	icct	Stock Issued For The Conversion Of Warrants Amount StockIssuedForTheConversionOfWarrantsAmount	-3500	usd
CY2023	icct	Merger Transaction Costs MergerTransactionCosts	208322	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15920362	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4444168	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15920362	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-6079824	usd
CY2023	us-gaap	Depreciation Depreciation	17429	usd
CY2022	us-gaap	Depreciation Depreciation	22521	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1269564	usd
CY2023	us-gaap	Financing Interest Expense FinancingInterestExpense	1287916	usd
CY2022	us-gaap	Financing Interest Expense FinancingInterestExpense	426419	usd
CY2023	icct	Bad Debt Expense BadDebtExpense	158620	usd
CY2022	icct	Bad Debt Expense BadDebtExpense	261717	usd
CY2023	icct	Change In Value Of Forward Purchase Agreement ChangeInValueOfForwardPurchaseAgreement	2312116	usd
CY2022	icct	Change In Value Of Forward Purchase Agreement ChangeInValueOfForwardPurchaseAgreement	0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1942036	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1717123	usd
CY2023	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-13778	usd
CY2022	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
CY2023	us-gaap	Dividends Dividends	368699	usd
CY2022	us-gaap	Dividends Dividends	0	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	167265	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	603146	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	105676	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	307716	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	47479	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	1244356	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	26420	usd
CY2023	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	-31034	usd
CY2022	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	-34386	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	907164	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	552424	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	105751	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-6572	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8824972	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1272995	usd
CY2023	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	1559144	usd
CY2022	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	0	usd
CY2023	icct	Investment In Forward Purchase Agreement InvestmentInForwardPurchaseAgreement	7796672	usd
CY2022	icct	Investment In Forward Purchase Agreement InvestmentInForwardPurchaseAgreement	0	usd
CY2023	us-gaap	Proceeds From Sale Of Other Assets1 ProceedsFromSaleOfOtherAssets1	28000	usd
CY2022	us-gaap	Proceeds From Sale Of Other Assets1 ProceedsFromSaleOfOtherAssets1	0	usd
CY2023	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	159878	usd
CY2022	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	4153	usd
CY2023	icct	Additions To Capitalized Software AdditionsToCapitalizedSoftware	-727021	usd
CY2022	icct	Additions To Capitalized Software AdditionsToCapitalizedSoftware	-289812	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10214715	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-293965	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	7796753	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3585000	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	1235399	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	2323181	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2881024	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	450000	usd
CY2023	icct	Conversion Of Convertible Debt Into Common Stock ConversionOfConvertibleDebtIntoCommonStock	0	usd
CY2022	icct	Conversion Of Convertible Debt Into Common Stock ConversionOfConvertibleDebtIntoCommonStock	-22387	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	18312897	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2100	usd
CY2023	icct	Effect Of Merger Net Of Transactions EffectOfMergerNetOfTransactions	-7692383	usd
CY2022	icct	Effect Of Merger Net Of Transactions EffectOfMergerNetOfTransactions	0	usd
CY2023	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	0	usd
CY2022	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	45000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1023205	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	124346	usd
CY2023	icct	Stock Issued For Acquisition Of Preferred Dental StockIssuedForAcquisitionOfPreferredDental	400000	usd
CY2022	icct	Stock Issued For Acquisition Of Preferred Dental StockIssuedForAcquisitionOfPreferredDental	0	usd
CY2023	icct	Stock Issued For Conversion Of Notes Payable StockIssuedForConversionOfNotesPayable	5765656	usd
CY2022	icct	Stock Issued For Conversion Of Notes Payable StockIssuedForConversionOfNotesPayable	22387	usd
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	1794704	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>1. NATURE OF OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">iCoreConnect Inc., (the “Company”), a Delaware Corporation, is a cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise platform of applications and services.</p>
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	17002897	usd
CY2023Q4	us-gaap	Secured Debt Repurchase Agreements SecuredDebtRepurchaseAgreements	12569810	usd
CY2023Q4	icct	Due From Officers Or Stockholders Or Related Party Current DueFromOfficersOrStockholdersOrRelatedPartyCurrent	4433087	usd
CY2023Q4	us-gaap	Sale Leaseback Transaction Historical Cost SaleLeasebackTransactionHistoricalCost	4433087	usd
CY2023Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	0	usd
CY2023	icct	Going Concern And Liquidity Policy Textblock GoingConcernAndLiquidityPolicyTextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">U. S. GAAP requires management to assess a company’s ability to continue as a going concern within one year from the financial statement issuance and to provide related note disclosures in certain circumstances. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the fiscal year period ended December 31, 2023, the Company generated an operating loss of $10,276,602. In addition, the Company has an accumulated deficit, and net working capital deficit of $115,038,758 and $5,367,985. The Company’s activities were primarily financed through private placements of equity securities and issuance of debt. The Company intends to raise additional capital through the issuance of debt and/or equity securities to fund its operations. The Company is reliant on future fundraising to finance operations in the near future. The financing may not be available on terms satisfactory to the Company, if at all. In light of these matters, there is substantial doubt that the Company will be able to continue as a going concern.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px">Currently, management continues to develop its healthcare communications system and continues to develop alliances with strategic partners to generate revenues that will sustain the Company. Management will also seek to raise additional funds. While management believes in the viability of its strategy to increase revenues and in its ability to raise additional funds, there can be no assurances to that effect. Management’s ability to continue as a going concern is ultimately dependent upon its ability to continually increase the Company’s customer base and realize increased revenues from signed contracts. The consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p>
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-10276602	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-115038758	usd
CY2023Q4	icct	Working Capital Deficit WorkingCapitalDeficit	-5367985	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	102061	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	65000	usd
CY2023	icct	Long Lived Assets And Goodwillpolicytextblock LongLivedAssetsAndGoodwillpolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, <em>Property, Plant and Equipment, Impairment or Disposal of Long-lived Assets</em>. This accounting standard requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. During December 31, 2023, the Company determined that the carrying value of certain customer relationships exceed their fair value and impairment of long-lived assets existed. The Company took an impairment of $105,676 and adjusted the value of customer relationships to their fair value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for goodwill and intangible assets in accordance with ASC 350, <em>Intangibles - Goodwill and Other</em>. Goodwill represents the excess of the purchase price of an entity over the estimated fair value of the assets acquired and liabilities assumed. ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. During the fourth quarter of 2020, the Company adopted ASU No. 2017-04, <em>Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</em>. This guidance simplifies the accounting for goodwill impairment by removing Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. Goodwill impairment will now be the amount by which the carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. As of December 31, 2023 the Company determined that the carrying value of certain customer relationships exceed their fair value and impairment existed in the amount of $105,676. The Company adjusted the value of its customer relationships to their fair value. As of December 31, 2023 and December 31, 2022, there is no impairment of the Company’s Goodwill.</p>
CY2023Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	105676	usd
CY2023	icct	Recurring Revenues RecurringRevenues	7400659	usd
CY2022	icct	Recurring Revenues RecurringRevenues	7206156	usd
CY2023	icct	Non Recurring Revenues NonRecurringRevenues	750928	usd
CY2022	icct	Non Recurring Revenues NonRecurringRevenues	781746	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	614061	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	525533	usd
CY2023	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for derivative instruments in accordance with ASC 815, which requires additional disclosures about the Company’s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for, and how the derivative instruments and related hedging items affect the financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. Terms of convertible debt and preferred stock instruments are reviewed to determine whether or not they contain embedded derivative instruments that are required under ASC 815 to be accounted for separately from the host contract and recorded on the balance sheet at fair value. The fair value of derivative liabilities, if any, is required to be revalued at each reporting date, with corresponding changes in fair value recorded in current period operating results.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Freestanding warrants issued by the Company in connection with the issuance or sale of debt and equity instruments are considered to be derivative instruments. Pursuant to ASC 815, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as equity or as a derivative liability.</p>
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.88
CY2022	icct	Weighted Average Remaining Contractual Term In Years Ending WeightedAverageRemainingContractualTermInYearsEnding	P8Y9M18D
CY2023	icct	Financial Instruments With Down Round Featurespolicytextblock FinancialInstrumentsWithDownRoundFeaturespolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">With respect to financial instruments, the Company follows the guidance of FASB ASU 2017-11, “Earnings per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features. Whereby ASU 2017-11 simplifies the accounting for certain financial instruments with down round features, a provision in an equity-linked financial instrument (or embedded feature) that provides a down round adjustment of the current exercise price based on the price of the future equity offerings. The standard requires companies to disregard the down round feature when assessing whether the instrument is indexed to its own stock, for the purposes of determining liability of equity classification. The Company accounts for instruments with Most Favored Nations (the “MFN”) terms or conditions similar to that of a down round feature. The impact of such terms or conditions will be accounted for when the event occurs. The Diluted EPS calculation for the effect of the feature when triggered (i.e. when the exercise price of the related equity-linked financial instrument is adjusted downward because of the down round feature) and will also recognize the effect of the trigger within equity.</p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and to the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</p>
CY2023	icct	Beneficial Conversion Features And Warrantspolicttextblock BeneficialConversionFeaturesAndWarrantspolicttextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company evaluates the conversion feature of convertible debt instruments to determine whether the conversion feature was beneficial as described in ASC 470-30, Debt with Conversion and Other Options. The Company records a beneficial conversion feature (“BCF”) related to the issuance of convertible debt that has conversion features at fixed or adjustable rates that are in-the-money when issued and records the relative fair value of any warrants issued with those instruments. The BCF for the convertible instruments is recognized and measured by allocating a portion of the proceeds to the warrants and as a reduction to the carrying amount of the convertible instrument equal to the intrinsic value of the conversion features, both of which are credited to additional paid-in capital. The Company calculates the fair value of warrants with the convertible instruments using the Black-Scholes valuation model.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Under these guidelines, the Company first allocates the value of the proceeds received from a convertible debt transaction between the convertible debt instrument and any other detachable instruments included in the transaction (such as warrants) on a relative fair value basis. A BCF is then measured as the intrinsic value of the conversion option at the commitment date, representing the difference between the effective conversion price and the Company’s stock price on the commitment date multiplied by the number of shares into which the debt instrument is convertible. The allocated value of the BCF and warrants are recorded as a debt discount and accreted over the expected term of the convertible debt as interest expense. If the intrinsic value of the BCF is greater than the proceeds allocated to the convertible debt instrument, the amount of the discount assigned to the BCF is limited to the amount of the proceeds allocated to the convertible debt instrument.</p>
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	icct	Restated Strike Price RestatedStrikePrice	1817123	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	100000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1094005	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.58
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y9M18D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10054	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.58
CY2022	icct	Weighted Average Remaining Contractual Term In Years Granted WeightedAverageRemainingContractualTermInYearsGranted	P9Y
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	23459	shares
CY2022	icct	Weighted Average Remaining Contractual Term In Years Exercised As Part Of Merger WeightedAverageRemainingContractualTermInYearsExercisedAsPartOfMerger	P5Y6M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	335	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.48
CY2022	icct	Weighted Average Remaining Contractual Term In Years Forfeited WeightedAverageRemainingContractualTermInYearsForfeited	P6Y2M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1080265	shares
CY2022Q4	icct	Common Stock Warrants CommonStockWarrants	13158	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	311049	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.58
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y9M18D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1034856	shares
CY2022	icct	Weighted Average Grant Date Fair Value Nonvested Beginning WeightedAverageGrantDateFairValueNonvestedBeginning	3.58
CY2022	icct	Weighted Average Remaining Years To Vest Nonvested Begining WeightedAverageRemainingYearsToVestNonvestedBegining	P9Y9M18D
CY2022	icct	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Granted Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsGrantedNumberOfShares	10054	shares
CY2022	icct	Weighted Average Grant Date Fair Values Nonvested Granted WeightedAverageGrantDateFairValuesNonvestedGranted	4.48
CY2022	icct	Weighted Average Remaining Years To Vest Nonvested Granted WeightedAverageRemainingYearsToVestNonvestedGranted	P9Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	275359	shares
CY2022	icct	Weighted Average Grant Date Fair Value Nonvested Vested WeightedAverageGrantDateFairValueNonvestedVested	0
CY2022	icct	Weighted Average Remaining Years To Vest Nonvested Vested WeightedAverageRemainingYearsToVestNonvestedVested	P8Y3M18D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	335	shares
CY2022	icct	Weighted Average Grant Date Fair Values Nonvested Forfeited Expired WeightedAverageGrantDateFairValuesNonvestedForfeitedExpired	4.13
CY2022	icct	Weighted Average Remaining Years To Vest Nonvested Forfeitedexpired Term WeightedAverageRemainingYearsToVestNonvestedForfeitedexpiredTerm	P9Y
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	769216	shares
CY2022	icct	Weighted Average Grant Date Fair Values Nonvested Ending WeightedAverageGrantDateFairValuesNonvestedEnding	3.58
CY2022	icct	Weighted Average Remaining Years To Vest Nonvested Ending WeightedAverageRemainingYearsToVestNonvestedEnding	P8Y9M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1080265	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.88
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y9M18D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7446	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.04
CY2023	icct	Weighted Average Remaining Contractual Term In Years Granted WeightedAverageRemainingContractualTermInYearsGranted	P9Y7M6D
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	310881	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.62
CY2023	icct	Weighted Average Remaining Contractual Term In Years Exercised As Part Of Merger WeightedAverageRemainingContractualTermInYearsExercisedAsPartOfMerger	P7Y7M6D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	502	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.81
CY2023	icct	Weighted Average Remaining Contractual Term In Years Forfeited WeightedAverageRemainingContractualTermInYearsForfeited	P7Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	776328	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.74
CY2023	icct	Weighted Average Remaining Contractual Term In Years Ending WeightedAverageRemainingContractualTermInYearsEnding	P8Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	381256	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.72
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y10M24D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	769216	shares
CY2023	icct	Weighted Average Grant Date Fair Value Nonvested Beginning WeightedAverageGrantDateFairValueNonvestedBeginning	3.58
CY2023	icct	Weighted Average Remaining Years To Vest Nonvested Begining WeightedAverageRemainingYearsToVestNonvestedBegining	P8Y9M18D
CY2023	icct	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Granted Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsGrantedNumberOfShares	7446	shares
CY2023	icct	Weighted Average Grant Date Fair Value Nonvested Vested WeightedAverageGrantDateFairValueNonvestedVested	6.04
CY2023	icct	Weighted Average Remaining Years To Vest Nonvested Granted WeightedAverageRemainingYearsToVestNonvestedGranted	P9Y7M6D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	381256	shares
CY2023	icct	Weighted Average Grant Date Fair Values Nonvested Granted WeightedAverageGrantDateFairValuesNonvestedGranted	3.72
CY2023	icct	Weighted Average Remaining Years To Vest Nonvested Vested WeightedAverageRemainingYearsToVestNonvestedVested	P7Y10M24D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	334	shares
CY2023	icct	Weighted Average Grant Date Fair Values Nonvested Forfeited Expired WeightedAverageGrantDateFairValuesNonvestedForfeitedExpired	4.13
CY2023	icct	Weighted Average Remaining Years To Vest Nonvested Forfeitedexpired Term WeightedAverageRemainingYearsToVestNonvestedForfeitedexpiredTerm	P9Y
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	395072	shares
CY2023	icct	Weighted Average Grant Date Fair Values Nonvested Ending WeightedAverageGrantDateFairValuesNonvestedEnding	3.76
CY2023	icct	Weighted Average Remaining Years To Vest Nonvested Ending WeightedAverageRemainingYearsToVestNonvestedEnding	P8Y
CY2023	us-gaap	Restricted Stock Expense RestrictedStockExpense	394168	usd
CY2022	icct	Issued Common Sttock Warrants Purchased IssuedCommonSttockWarrantsPurchased	1278	shares
CY2022	icct	Warrants To Be Issued Additional WarrantsToBeIssuedAdditional	28883	shares
CY2022Q4	icct	Strike Price StrikePrice	0.15
CY2022Q4	icct	Restated Strike Price RestatedStrikePrice	45000	usd
CY2023	icct	Warrants To Be Issued Additional WarrantsToBeIssuedAdditional	1424	shares
CY2023Q4	icct	Common Stock Warrants CommonStockWarrants	45129	shares
CY2022	icct	Purchase Price Description PurchasePriceDescription	The Company issued convertible debt in December 2022 at a price of $2.39 thereby affecting the down round provision on 659,585 warrants with a trigger price that is lower than $0.30 for any equity instrument issued. As such the Company has recorded a charge of $1,794,704 as a Dividend to Common Stockholders reflecting the increase in value of shares to be received by the warrant holder along with an increase in 366,331 warrants issuable to these holders for a total of 1,014,791 warrants at a new exercise price of $2.39
CY2021Q4	icct	Number Of Warrants Outstanding NumberOfWarrantsOutstanding	648461	shares
CY2022	icct	Weighted Average Exercise Price Of Warrants Beginning WeightedAverageExercisePriceOfWarrantsBeginning	3.88
CY2022	icct	Weighted Average Remaining Life Of Warrants In Years Beginning WeightedAverageRemainingLifeOfWarrantsInYearsBeginning	P4Y4M24D
CY2023	icct	Aggregate Intrinsic Value Of Warrants Beginning AggregateIntrinsicValueOfWarrantsBeginning	0	usd
CY2022	icct	Number Of Warrants Granted NumberOfWarrantsGranted	379492	shares
CY2022	icct	Weighted Average Exercise Price Of Warrants Granted WeightedAverageExercisePriceOfWarrantsGranted	2.39
CY2022	icct	Weighted Average Remaining Life Of Warrants In Years Exercised WeightedAverageRemainingLifeOfWarrantsInYearsExercised	P3Y4M24D
CY2022Q4	icct	Number Of Warrants Outstanding NumberOfWarrantsOutstanding	1027953	shares
CY2023	icct	Weighted Average Exercise Price Of Warrants Beginning WeightedAverageExercisePriceOfWarrantsBeginning	3.88
CY2023	icct	Weighted Average Remaining Life Of Warrants In Yearsgranted WeightedAverageRemainingLifeOfWarrantsInYearsgranted	P3Y5M12D
CY2023	icct	Number Of Warrants Granted NumberOfWarrantsGranted	45129	shares
CY2023	icct	Weighted Average Exercise Price Of Warrants Granted WeightedAverageExercisePriceOfWarrantsGranted	2.09
CY2023	icct	Weighted Average Remaining Life Of Warrants In Years Beginning WeightedAverageRemainingLifeOfWarrantsInYearsBeginning	P5Y
CY2023	icct	Number Of Warrants Exercised NumberOfWarrantsExercised	-368368	shares
CY2023	icct	Weighted Average Exercise Price Of Warrants Exercised WeightedAverageExercisePriceOfWarrantsExercised	3.88
CY2023	icct	Weighted Average Remaining Life Of Warrants In Years Exercised WeightedAverageRemainingLifeOfWarrantsInYearsExercised	P2Y9M10D
CY2023	icct	Number Of Warrants Cancelled NumberOfWarrantsCancelled	-659585	shares
CY2023	icct	Weighted Average Exercise Price Of Warrants Cancelled WeightedAverageExercisePriceOfWarrantsCancelled	3.88
CY2022	icct	Weighted Average Remaining Life Of Warrants In Years Cancelled WeightedAverageRemainingLifeOfWarrantsInYearsCancelled	P2Y9M10D
CY2023Q4	icct	Number Of Warrants Outstanding NumberOfWarrantsOutstanding	45129	shares
CY2023	icct	Weighted Average Exercise Price Of Warrants Ending WeightedAverageExercisePriceOfWarrantsEnding	2.09
CY2023	icct	Weighted Average Remaining Life Of Warrants In Years Cancelled WeightedAverageRemainingLifeOfWarrantsInYearsCancelled	P4Y9M18D
CY2023	icct	Aggregate Intrinsic Value Of Warrants Ending AggregateIntrinsicValueOfWarrantsEnding	0	usd
CY2023Q3	us-gaap	Customer Advances Current CustomerAdvancesCurrent	15000000	usd
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	291259	shares
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	600000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	282256	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	154378	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	79835	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	80184	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	202421	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	74194	usd
CY2023	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	17429	usd
CY2022	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	22521	usd
CY2023	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-13778	usd
CY2023	icct	Recovery Of Depreciation Expense RecoveryOfDepreciationExpense	17778	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1484966	usd
CY2022	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1484966	usd
CY2023	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1484966	usd
CY2023	icct	Schedule Of Carrying Amounts And Accumulated Amortization ScheduleOfCarryingAmountsAndAccumulatedAmortization	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Gross </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Carrying</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Impairment</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amortization</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Net </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Carrying</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Definite-lived intangible assets at January 1, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Capitalized software</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,014,490</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,483,429 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">531,061</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Customer relationships</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,713,434</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,363,054 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,350,380</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Acquired technology</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,527,186</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,447,758 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">79,428</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total definite-lived intangible assets at December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,255,110</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5,294,241 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,960,869</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Capitalized software</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,741,511</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,838,099 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">903,412</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Customer relationships</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,272,578</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(105,676 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,186,490 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,980,412</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Acquired technology</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,527,186</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,527,186 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total definite-lived intangible assets at December 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">10,541,275</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(105,676 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(6,551,775 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3,883,824</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8255110	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-5294241	usd
CY2022Q4	icct	Finite Lived Intangible Asset Net Carrying Amount FiniteLivedIntangibleAssetNetCarryingAmount	2960869	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10541275	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	105676	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-6551775	usd
CY2023Q4	icct	Finite Lived Intangible Asset Net Carrying Amount FiniteLivedIntangibleAssetNetCarryingAmount	3883824	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1257534	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1269564	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1357783	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1357783	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1087976	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	80282	usd
CY2023	icct	Forward Purchase Agreementdisclosuretextblock ForwardPurchaseAgreementdisclosuretextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>7. FORWARD PURCHASE AGREEMENT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 14, 2023, the Company entered into Prepaid Forward Purchase Agreement (the “FPA”) with Old iCore and RiverNorth SPAC Arbitrage Fund, L.P., a Delaware limited partnership (the “Purchaser”).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In accordance with the FPA and subject to the terms and conditions set forth therein, the Purchaser purchased the lesser of (a) 1.5 million shares of FGMC Common Stock and (b) such number of shares of FGMC Common Stock as shall, following the Business Combination, not exceed 9.9% of the total number of shares of FGMC Common Stock to be outstanding (such shares to be purchased, the “Forward Purchase Shares”) from public shareholders for a price no greater than the redemption price per share as is indicated in FGMC’s most recently filed periodic report (the “Prepaid Forward Purchase Price”).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In accordance with the terms of the Business Combination, upon the consummation of the Business Combination, each Forward Purchase Share automatically converted into one share of Preferred Stock (including the shares of the Company’s Common Stock underlying the Preferred Stock, the “Purchased Shares”).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upon the Business Combination closing, 100,000 Purchased Shares were deemed to be “Commitment Shares” and the remaining Purchased Shares were deemed to be “Prepaid Forward Purchase Shares”.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upon the closing of the Business Combination FGMC caused Purchaser to be paid directly out of the funds held in FGMC’s trust account, a cash amount (the “Prepayment Amount”) equal to the number of Purchased Shares multiplied by the amount paid to redeeming stockholders in connection with the Business Combination (the “Redemption Price”). The Redemption Price was $10.69.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upon the sale of the Prepaid Forward Purchase Shares (or underlying FGMC Common Stock) by the Purchaser, the Purchaser will remit the Reference Price (as defined below) per share to FGMC. On the earlier to occur of: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the occurrence of a “Registration Failure” (as defined in the FPA), and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the date that is twelve months after the closing of the Business Combination (the “Maturity Date”), then, for any Common Stock underlying the Prepaid Forward Purchase Shares not sold by the Purchaser, the Purchaser shall, on the 25th trading day after the Maturity Date (the “Payment Date”), pay the Company an amount equal to (i) the number of Prepaid Forward Purchase Shares that the Purchaser held on the Maturity Date, multiplied by (ii) the lowest daily volume weighted average price per share of FGMC Common Stock during the twenty trading days beginning on the day after the Maturity Date less $0.15.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Between the Maturity Date and the Payment Date, the Purchaser may not sell more than a number of Prepaid Forward Purchase Shares per day equal to the greater of (i) 5% of the Purchased Shares owned by the Purchaser at the Maturity Date and (ii) 10% of the daily trading volume on such date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Purchaser has agreed that until the Maturity Date, the Common Stock underlying the Prepaid Forward Purchase Shares may not be sold for a price less than the Reference Price. The “Reference Price” will initially equal the Redemption Price and will be reduced (but never increased) each month commencing on the first day of the month starting 30 days after the Business Combination closing to the volume weighted average price of the FGMC Common Stock for the preceding 10 trading days, but in no event less than $10.00 per share (the “Floor”) unless in the Company’s sole discretion, the Floor is lowered. Any reduction of the Floor shall be accomplished through a written notice from the Company to Purchaser.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The FPA provides for certain registration rights. In particular, FGMC is required to, within 30 calendar days following written request by Purchaser, file with the SEC a registration statement registering the resale of all shares held by Purchaser and have such registration statement declared effective as soon as practicable after the filing thereof.</p>
CY2023	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	100000	shares
CY2023	icct	Redemption Price Per Shares RedemptionPricePerShares	10.69
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	6337429	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	5491570	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2023Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	196837	usd
CY2022Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	7444	usd
CY2023Q4	icct	Total Notes Payable Net Of Financing Costs TotalNotesPayableNetOfFinancingCosts	6140592	usd
CY2022Q4	icct	Total Notes Payable Net Of Financing Costs TotalNotesPayableNetOfFinancingCosts	5484126	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4720455	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4034865	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1420137	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1449261	usd
CY2023Q3	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	2500000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	115535	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares Conversion Of Units StockIssuedDuringPeriodSharesConversionOfUnits	876522	shares
CY2023Q3	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1200000	usd
CY2023Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.12	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	27559000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	62985000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	5900000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	19676000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	14849000	usd
CY2023Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	926000	usd
CY2022Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	74000	usd
CY2023Q4	icct	Stock Issued During Period Values Share Based Compensation StockIssuedDuringPeriodValuesShareBasedCompensation	433000	usd
CY2022Q4	icct	Stock Issued During Period Values Share Based Compensation StockIssuedDuringPeriodValuesShareBasedCompensation	418000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	12000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	140000	usd
CY2023Q4	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	25000	usd
CY2022Q4	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	0	usd
CY2023Q4	icct	Forward Purchase Agreement Taxes ForwardPurchaseAgreementTaxes	562000	usd
CY2022Q4	icct	Forward Purchase Agreement Taxes ForwardPurchaseAgreementTaxes	0	usd
CY2023Q4	us-gaap	Other Payables To Broker Dealers And Clearing Organizations OtherPayablesToBrokerDealersAndClearingOrganizations	224000	usd
CY2022Q4	us-gaap	Other Payables To Broker Dealers And Clearing Organizations OtherPayablesToBrokerDealersAndClearingOrganizations	195000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	289000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	22123000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15396000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	273000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	273000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21850000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15396000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	icct	Effective Income Tax Rate Permanent Differences Percent EffectiveIncomeTaxRatePermanentDifferencesPercent	-0.03	pure
CY2022	icct	Effective Income Tax Rate Permanent Differences Percent EffectiveIncomeTaxRatePermanentDifferencesPercent	-0.02	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.03	pure
CY2023	icct	Cumulative Adjustments Taxes CumulativeAdjustmentsTaxes	0.23	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.41	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.22	pure
CY2023Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	250000	usd
CY2023	icct	Schedule Of Undiscounted Future Lease Obligations ScheduleOfUndiscountedFutureLeaseObligations	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px"><td colspan="15" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Lease Commitments</strong></p></td></tr><tr style="height:15px"><td colspan="15" style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>as of December 31, 2023</strong></p></td></tr><tr style="height:15px"><td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Less than 1 year</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>1-3 years</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>3-5 years</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td>369,849</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,059,423</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">89,038</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,518,310</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q4	us-gaap	Other Commitment OtherCommitment	1518310	usd
CY2023	icct	Schedule Of Undiscounted Minimum Lease Commitments ScheduleOfUndiscountedMinimumLeaseCommitments	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Undiscounted minimum lease commitments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,518,310</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: Imputed Interest</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(330,476 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,187,834</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2021Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	270020	usd
CY2023Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	523415	usd
CY2023Q1	icct	Damage Claim Settlement Amount Under Act DamageClaimSettlementAmountUnderAct	635000	usd
CY2023Q3	icct	Notes Payable Acquire NotesPayableAcquire	1200000	usd
CY2023Q3	icct	Acquisition Of Common Stock AcquisitionOfCommonStock	400000	usd
CY2023Q3	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	10
CY2023Q3	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	40000	shares
CY2023	icct	Annual Customer Attrition Rate AnnualCustomerAttritionRate	0.05	pure
CY2023	icct	Gross Margin Percentage GrossMarginPercentage	0.37	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2550	pure
CY2023	us-gaap	Workers Compensation Discount Percent WorkersCompensationDiscountPercent	0.12	pure
CY2023Q3	icct	Notes Payable Acquire NotesPayableAcquire	1200000	usd
CY2023Q3	icct	Acquisition Of Common Stock AcquisitionOfCommonStock	400000	usd
CY2023Q3	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	1600000	usd
CY2023Q3	us-gaap	Acquisition Costs AcquisitionCosts	40855	usd
CY2023Q3	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1559145	usd
CY2023Q3	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	1600000	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	9311714	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	9058801	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-15433055	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7611211	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7349541	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5768249	shares
CY2023	icct	Basic And Diluted Loss Per Common Share BasicAndDilutedLossPerCommonShare	-2.10
CY2022	icct	Basic And Diluted Loss Per Common Share BasicAndDilutedLossPerCommonShare	-1.32

Files In Submission

Name	View Source	Status
0001477932-24-002244-index-headers.html	Edgar Link	pending
0001477932-24-002244-index.html	Edgar Link	pending
0001477932-24-002244.txt	Edgar Link	pending
0001477932-24-002244-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
icct-20231231.xsd	Edgar Link	pending
icct_10k.htm	Edgar Link	pending
icct_ex231.htm	Edgar Link	pending
icct_ex311.htm	Edgar Link	pending
icct_ex312.htm	Edgar Link	pending
icct_ex321.htm	Edgar Link	pending
icct_ex322.htm	Edgar Link	pending
icct_ex97.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
icct-20231231_def.xml	Edgar Link	unprocessable
icct-20231231_lab.xml	Edgar Link	unprocessable
icct-20231231_pre.xml	Edgar Link	unprocessable
icct_10k_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
icct-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICCT
iCoreConnect Inc. Stock $icct

2024 Q2 Form 10-K Financial Statement

#000147793224002244 Filed on April 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICCT iCoreConnect Inc. Stock $icct

2024 Q2 Form 10-K Financial Statement

#000147793224002244 Filed on April 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICCT
iCoreConnect Inc. Stock $icct